Skip to main content
. Author manuscript; available in PMC: 2018 Oct 10.
Published in final edited form as: J Am Coll Surg. 2018 Jan 5;226(4):630–637.e1. doi: 10.1016/j.jamcollsurg.2017.12.021

Figure 3.

Figure 3.

Kaplan-Meier overall survival estimates of BRCA1/BRCA2 germline mutated patients after resection of pancreatic adenocarcinoma stratified by type of chemotherapy received. Platinum-based chemotherapy vs other chemotherapy (p < 0.01) vs no chemotherapy (p < 0.01). Other chemotherapy vs no chemotherapy (p = 0.053).